Add to ORKGBackground: The role of lipoprotein(a) [Lp(a)] as a predictor of cardiovascular disease (CVD) in patients with heterozygous familial hypercholesterolemia (HFH) is unclear. We sought to examine the utility of this lipoprotein as a predictor of CVD outcomes in the HFH population at our lipid clinic. Methods: This was a retrospective analysis of clinical and laboratory data from a large multiethnic cohort of HFH patients at a single, large lipid clinic in Vancouver, Canada. Three hundred and eighty-eight patients were diagnosed with possible, probable, or definite HFH by strict clinical diagnostic criteria. Multivariate Cox re-gression analysis was used to study the relationship between several established CVD risk factors, Lp(a), and the age ...
Background and aims Little is known about the role of Lp(a) in the assessment of cardiovascular ris...
Aim: Familial Hypercholesterolemia (FH) patients have an increased cardiovascular risk due to high T...
Background: Lipoprotein (a) [Lp (a)] is an established risk marker of coronary artery disease which ...
Background: The role of lipoprotein(a) [Lp(a)] as a predictor of cardiovascular disease (CVD) in pat...
ObjectivesThe aim of this study was to determine the relationship between lipoprotein(a) [Lp(a)] and...
Background: Heterozygous Familial hypercholesterolemia (FH) is a common autosomal d...
Background: Familial hypercholesterolemia (FH) is a common autosomal dominant disorder caused by mu...
BACKGROUND: Heterozygous familial hypercholesterolemia (hFH) and familial combined hyperlipidemia (F...
Lipoprotein(a) (Lp[a]) is a strong genetic risk factor for cardiovascular disease (CVD). The America...
Familial hypercholesterolemia (FH) is a common genetic cause of elevated low-density lipoprotein cho...
Background: Large-scale prospective data are needed to determine whether associations between lipopr...
Background and aims: Little is known about the role of Lp(a) in the assessment of cardiovascular ris...
Background: Increased lipoprotein(a) [Lp(a)] concentrations are predictive for coronary artery disea...
Background and aims: Little is known about the role of Lp(a) in the assessment of cardiovascular ris...
Background: Lipoprotein(a) [Lp(a)] is composed of a low density-lipoprotein (LDL) particle and a gly...
Background and aims Little is known about the role of Lp(a) in the assessment of cardiovascular ris...
Aim: Familial Hypercholesterolemia (FH) patients have an increased cardiovascular risk due to high T...
Background: Lipoprotein (a) [Lp (a)] is an established risk marker of coronary artery disease which ...
Background: The role of lipoprotein(a) [Lp(a)] as a predictor of cardiovascular disease (CVD) in pat...
ObjectivesThe aim of this study was to determine the relationship between lipoprotein(a) [Lp(a)] and...
Background: Heterozygous Familial hypercholesterolemia (FH) is a common autosomal d...
Background: Familial hypercholesterolemia (FH) is a common autosomal dominant disorder caused by mu...
BACKGROUND: Heterozygous familial hypercholesterolemia (hFH) and familial combined hyperlipidemia (F...
Lipoprotein(a) (Lp[a]) is a strong genetic risk factor for cardiovascular disease (CVD). The America...
Familial hypercholesterolemia (FH) is a common genetic cause of elevated low-density lipoprotein cho...
Background: Large-scale prospective data are needed to determine whether associations between lipopr...
Background and aims: Little is known about the role of Lp(a) in the assessment of cardiovascular ris...
Background: Increased lipoprotein(a) [Lp(a)] concentrations are predictive for coronary artery disea...
Background and aims: Little is known about the role of Lp(a) in the assessment of cardiovascular ris...
Background: Lipoprotein(a) [Lp(a)] is composed of a low density-lipoprotein (LDL) particle and a gly...
Background and aims Little is known about the role of Lp(a) in the assessment of cardiovascular ris...
Aim: Familial Hypercholesterolemia (FH) patients have an increased cardiovascular risk due to high T...
Background: Lipoprotein (a) [Lp (a)] is an established risk marker of coronary artery disease which ...